Kathryn M Milne1, Joanne M Kwan1, Sabina Guler2, Tiffany A Winstone1, Angela Le1, Nasreen Khalil1, Pat G Camp3,4, Pearce G Wilcox1, Christopher J Ryerson1,4. 1. Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. 2. Department of Pulmonary Medicine, University Hospital and University of Bern, Bern, Switzerland. 3. Department of Physical Therapy, University of British Columbia, Vancouver, British Columbia, Canada. 4. Centre for Heart Lung Innovation, University of British Columbia, Vancouver, British Columbia, Canada.
Abstract
BACKGROUND AND OBJECTIVE: Frailty is the age-related accumulation of deficits that decrease the ability to respond to biological stress. Patients with fibrotic interstitial lung disease (ILD) may be frail due to consequences of ILD, age, co-morbidities and adverse effects of pharmacotherapies. The objective of this study was to examine the prevalence and predictors of frailty in fibrotic ILD. METHODS: Fibrotic ILD patients were recruited from a specialized clinic. Patients with ILD secondary to a systemic disease were excluded. Frailty was determined using the Frailty Index based on the presence or absence of multiple deficits, including co-morbidities, symptoms and functional limitations. The Frailty Index was based on the proportion of deficits present, with frailty defined as a score >0.21. Cronbach's alpha was used to estimate the internal consistency of the Frailty Index. Dyspnoea was measured using the University of California San Diego Shortness of Breath Questionnaire. Multivariate analysis was used to determine independent predictors of frailty. RESULTS: The definition of frailty was met in 50% of the 129 patients. Cronbach's alpha for the Frailty Index was 0.87. The Frailty Index was associated with forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1 ), diffusion capacity of the lung for carbon monoxide (DLCO ), ILD-gender, age and physiology (GAP) index, composite physiologic index and dyspnoea score. Dyspnoea severity was the strongest unadjusted predictor (r = 0.65, P < 0.001) and only independent predictor of the Frailty Index (0.034 increase in Frailty Index per 10-point increase in dyspnoea score; R2 = 0.37; P < 0.001). CONCLUSION: Frailty is highly prevalent and is strongly and independently associated with dyspnoea severity, demonstrating that dyspnoea is a more important determinant of frailty than pulmonary function.
BACKGROUND AND OBJECTIVE: Frailty is the age-related accumulation of deficits that decrease the ability to respond to biological stress. Patients with fibrotic interstitial lung disease (ILD) may be frail due to consequences of ILD, age, co-morbidities and adverse effects of pharmacotherapies. The objective of this study was to examine the prevalence and predictors of frailty in fibrotic ILD. METHODS:Fibrotic ILDpatients were recruited from a specialized clinic. Patients with ILD secondary to a systemic disease were excluded. Frailty was determined using the Frailty Index based on the presence or absence of multiple deficits, including co-morbidities, symptoms and functional limitations. The Frailty Index was based on the proportion of deficits present, with frailty defined as a score >0.21. Cronbach's alpha was used to estimate the internal consistency of the Frailty Index. Dyspnoea was measured using the University of California San Diego Shortness of Breath Questionnaire. Multivariate analysis was used to determine independent predictors of frailty. RESULTS: The definition of frailty was met in 50% of the 129 patients. Cronbach's alpha for the Frailty Index was 0.87. The Frailty Index was associated with forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1 ), diffusion capacity of the lung for carbon monoxide (DLCO ), ILD-gender, age and physiology (GAP) index, composite physiologic index and dyspnoea score. Dyspnoea severity was the strongest unadjusted predictor (r = 0.65, P < 0.001) and only independent predictor of the Frailty Index (0.034 increase in Frailty Index per 10-point increase in dyspnoea score; R2 = 0.37; P < 0.001). CONCLUSION: Frailty is highly prevalent and is strongly and independently associated with dyspnoea severity, demonstrating that dyspnoea is a more important determinant of frailty than pulmonary function.
Authors: Michaela R Anderson; Nicholas A Kolaitis; Ying Gao; Jasleen Kukreja; John Greenland; Steven Hays; Paul Wolters; Jeff Golden; Joshua Diamond; Scott Palmer; Selim Arcasoy; Jayaram Udupa; Jason D Christie; David J Lederer; Jonathan P Singer Journal: Am J Transplant Date: 2019-07-24 Impact factor: 8.086
Authors: Jeffrey A Sparks; Tracy J Doyle; Xintong He; Beatrice Pan; Christine Iannaccone; Michelle L Frits; Paul F Dellaripa; Ivan O Rosas; Bing Lu; Michael E Weinblatt; Nancy A Shadick; Elizabeth W Karlson Journal: ACR Open Rheumatol Date: 2019-03-15
Authors: J H Fisher; M Kolb; M Algamdi; J Morisset; K A Johannson; S Shapera; P Wilcox; T To; M Sadatsafavi; H Manganas; N Khalil; N Hambly; A J Halayko; A S Gershon; C D Fell; G Cox; C J Ryerson Journal: BMC Pulm Med Date: 2019-11-27 Impact factor: 3.317